News
Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...
Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...
8h
inews.co.uk on MSNGPs swamped by requests for NHS Mounjaro – but hardly anyone qualifiesThousands taking Mounjaro privately are inundating GP surgeries - clogging phone lines, exacerbating the 8am scramble for ...
9h
Zacks.com on MSNNVO vs. LLY: Which Obesity Powerhouse is the Stronger Bet Now?Eli Lilly edges ahead of Novo Nordisk as the stronger obesity bet, backed by robust sales growth, pipeline depth and ...
9h
The i Paper on MSNGPs swamped by requests for NHS Mounjaro - but no one qualifiesThousands taking Mounjaro privately are inundating GP surgeries - clogging phone lines, exacerbating the 8am scramble for ...
A cyberattack on Synnovis has been linked to a patient's death at King's College Hospital, marking a serious hacking ...
23h
Health and Me on MSNEli Lilly’s Mounjaro Kwikpen Gets Indian Approval For Diabetes And Weight LossIndia approves Eli Lilly’s Mounjaro KwikPen, a once-weekly injection for type 2 diabetes and obesity, offering dual hormone ...
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
17hon MSN
Exclusive: Julie Bishop lost two-and-a-half stone in eight weeks by taking Mounjaro before she was sent to hospital with ...
Mounjaro users in the UK have to jump through quite a few hoops to get their hands on the weight-loss drug. You might think ...
Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of ...
22h
Stocktwits on MSNGLP-1 Showdown In India: Eli Lilly’s Mounjaro Pen Approved Just Days After Novo’s Wegovy LaunchIndia’s health regulator has approved Eli Lilly’s pre-filled pen version of Mounjaro, expanding its availability across six ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results